Cipla surges on the bourses

11 Jun 2018 Evaluate

Cipla is currently trading at Rs. 564.55, up by 6.30 points or 1.13% from its previous closing of Rs. 558.25 on the BSE.

The scrip opened at Rs. 559.00 and has touched a high and low of Rs. 569.90 and Rs. 558.70 respectively. So far 52443 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 663.00 on 07-Nov-2017 and a 52 week low of Rs. 508.10 on 22-May-2018.

Last one week high and low of the scrip stood at Rs. 569.90 and Rs. 517.80 respectively. The current market cap of the company is Rs. 45558.86 crore.

The promoters holding in the company stood at 37.21%, while Institutions and Non-Institutions held 38.10% and 24.69% respectively.

Cipla is bullish on growth and is aiming for $1 billion consolidated revenue for the domestic market in FY19. The country’s fourth-largest drug maker reported revenues of Rs 15,219 crore, growing 6 per cent, with income from the India operations seeing a 6.3 per cent jump at Rs 5,687 crore in FY18.

The drug maker is expecting the in-licensing deals with innovator companies, focus on certain therapeutic segments and sales force productivity optimisation measures to aid growth in India.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1466.15 5.55 (0.38%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×